Replies to post #118743 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Just think what that puppy could do if combined with DCVax and PLX-3397. Plus Keytruda's dosing could be reduced.

This is the first time the agency has approved a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated. - https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm560167.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery

[Tadasana]

Wow, Falconx, DC-Vax Direct to the rescue! Great news approval based on biomarkers, all solid cancers. Thanks for the update.

[Evaluate]

Seems to me that this could bode well for NWBO, in that Bazdur et al might be getting a bit more creative in getting some treatments approved based on "efficacy of some" .... but perhaps not "efficacy for all". Might be helpful in the instance of DCVax-L?